financetom
Business
financetom
/
Business
/
OFFICIAL CORRECTION-Adidas plans cheaper versions of popular shoes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OFFICIAL CORRECTION-Adidas plans cheaper versions of popular shoes
May 18, 2024 8:28 AM

(Corrects May 16 story to reflect error in live translation,

Adidas is making cheaper versions for Deichmann and Intersport,

not Foot Locker ( FL ))

By Linda Pasquini

May 16 (Reuters) - Adidas is launching cheaper versions

of its three-striped shoes like the white and black suede Samba

as it aims to spread the trend, CEO Bjorn Gulden said on

Thursday at the company's annual shareholders' meeting in

Germany.

"It's important to understand that not everyone can afford

to buy a shoe for 120 or 150, but everyone wants to

take part in the same trends," Gulden told investors in a

presentation in Furth, near Adidas' headquarters in

Herzogenaurach.

Adidas will offer similar versions of the Samba and other

shoes for $60 to $80, more affordable entry points than the $100

to $150 price tag for the main shoe lines, according to a

presentation slide shown by Gulden.

"What we do at the top, 100 and higher, we're

bringing that down," Gulden said. The cheaper models are aimed

at retailers like Deichmann and Intersport, he added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nigeria blocks Shell's asset sale in the Niger Delta
Nigeria blocks Shell's asset sale in the Niger Delta
Oct 21, 2024
ABUJA, Oct 21 (Reuters) - Nigeria has blocked the sale of Shell's entire onshore and shallow-water oil and gas assets in the Niger Delta, the country's upstream regulator said on Monday, roughly 10 months after the deal was announced. In a speech at an event in the capital Abuja, Nigerian Upstream Petroleum Regulatory Commission (NUPRC) CEO Gbenga Komolafe said the...
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
Oct 21, 2024
Sanofi SA ( SNY ) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to potentially sell and purchase a 50% controlling stake in Opella, Sanofi’s consumer health unit.   The new step in Opella’s journey paves the way for creating a standalone player in consumer healthcare while supporting Sanofi’s strategy and increased focus on innovative...
Regenxbio Reports 97% Reduction in Injection Need for Wet AMD; Shares Rise Pre-Bell
Regenxbio Reports 97% Reduction in Injection Need for Wet AMD; Shares Rise Pre-Bell
Oct 21, 2024
09:08 AM EDT, 10/21/2024 (MT Newswires) -- Regenxbio ( RGNX ) reported Monday a 97% reduction in anti-VEGF injections at nine months in a Phase II study of ABBV-RGX-314 for wet age-related macular degeneration, or AMD. In the subretinal treatment of the second eye, 78% of patients remained injection-free, the company said. Visual acuity and retinal thickness were maintained, with...
Aura Biosciences Insider Sold Shares Worth $300,839, According to a Recent SEC Filing
Aura Biosciences Insider Sold Shares Worth $300,839, According to a Recent SEC Filing
Oct 21, 2024
08:45 AM EDT, 10/21/2024 (MT Newswires) -- Elisabet de los Pinos, Director, President and Chief Executive Officer, on October 18, 2024, sold 24,992 shares in Aura Biosciences ( AURA ) for $300,839. Following the Form 4 filing with the SEC, Elisabet de los Pinos has control over a total of 461,259 shares of the company, with 329,847 shares held directly...
Copyright 2023-2025 - www.financetom.com All Rights Reserved